Methods of reducing porphyrin toxicity using fatty acids
US5589509A · kind A · utility
15Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 6, 1996 |
| Grant date | Dec 31, 1996 |
| Priority date | — |
| Expiry date | Mar 6, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprises a polyunsaturated fatty acid, in particular an essential fatty acid of the n-6 series (linoleic acid or its metabolites) or the n-3 series (alpha-linolenic acid and its metabolites), together with a drug that taken alone has a side-effect of sensitizing the skin to light, in particular a porphyrin or tetracycline or Benoxaprofen, alone or in a pharmaceutically acceptable diluent or carrier, the composition reducing that sensitization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.